Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Number of holders
-
326
-
Total 13F shares, excl. options
-
254,094,050
-
Shares change
-
+5,773,423
-
Total reported value, excl. options
-
$7,533,999,824
-
Value change
-
+$401,339,258
-
Put/Call ratio
-
65%
-
Number of buys
-
171
-
Number of sells
-
171
-
Price
-
$29.65
Institutional Holders of IMMUNOGEN INC - COMMON STOCK (IMGN) as of Q4 2023
As of 31 Dec 2023 IMMUNOGEN INC - COMMON STOCK (IMGN) had 448 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 254,094,050 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., Redmile Group, LLC, JANUS HENDERSON GROUP PLC, STATE STREET CORP, Fairmount Funds Management LLC, Pentwater Capital Management LP, NORGES BANK, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 448 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.